批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2020/11/05 |
SUPPL-43(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/11/05 |
SUPPL-40(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/05/10 |
SUPPL-38(补充) |
Approval |
Labeling |
|
|
|
2011/01/26 |
SUPPL-36(补充) |
Approval |
Labeling |
|
|
|
2009/05/04 |
SUPPL-35(补充) |
Approval |
Labeling |
|
|
|
2007/03/28 |
SUPPL-34(补充) |
Approval |
Labeling |
|
|
|
2002/05/23 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2002/05/07 |
SUPPL-29(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2002/05/07 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2002/05/07 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2001/08/30 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2001/08/30 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/09/10 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1997/04/22 |
SUPPL-23(补充) |
Approval |
Labeling |
|
|
|
1996/08/28 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/04/13 |
SUPPL-21(补充) |
Approval |
Labeling |
|
|
|
1994/06/24 |
SUPPL-20(补充) |
Approval |
Labeling |
|
|
|
1992/08/28 |
SUPPL-19(补充) |
Approval |
Labeling |
|
|
|
1991/11/18 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/05/03 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/05/03 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/03/13 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/03/13 |
SUPPL-3(补充) |
Approval |
Labeling |
|
|
|
1991/03/13 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1990/12/18 |
SUPPL-15(补充) |
Approval |
Labeling |
|
|
|
1989/12/28 |
SUPPL-13(补充) |
Approval |
Labeling |
|
|
|
1989/04/19 |
SUPPL-9(补充) |
Approval |
Labeling |
|
|
|
1988/09/13 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1988/07/12 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1988/05/06 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
1986/01/24 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
1985/05/13 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:FUROSEMIDE 剂型/给药途径:TABLET;ORAL 规格:80MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016273 |
003 |
NDA |
LASIX |
FUROSEMIDE |
TABLET;ORAL |
80MG |
Prescription |
Yes |
Yes |
AB |
Approved Prior to Jan 1, 1982
|
VALIDUS PHARMS |
018569 |
005 |
NDA |
FUROSEMIDE |
FUROSEMIDE |
TABLET;ORAL |
80MG |
Prescription |
No |
No |
AB |
1984/08/14
|
EPIC PHARMA LLC |
070086 |
001 |
ANDA |
FUROSEMIDE |
FUROSEMIDE |
TABLET;ORAL |
80MG |
Prescription |
No |
No |
AB |
1986/01/24
|
HIKMA |
070082 |
001 |
ANDA |
FUROSEMIDE |
FUROSEMIDE |
TABLET;ORAL |
80MG |
Discontinued |
No |
No |
AB |
1986/10/29
|
MYLAN |
076796 |
003 |
ANDA |
FUROSEMIDE |
FUROSEMIDE |
TABLET;ORAL |
80MG |
Prescription |
No |
No |
AB |
2004/03/26
|
PRINSTON INC |
077293 |
003 |
ANDA |
FUROSEMIDE |
FUROSEMIDE |
TABLET;ORAL |
80MG |
Prescription |
No |
No |
AB |
2005/11/09
|
LEADING |
078010 |
003 |
ANDA |
FUROSEMIDE |
FUROSEMIDE |
TABLET;ORAL |
80MG |
Prescription |
No |
No |
AB |
2006/09/18
|
IPCA LABS LTD |
216629 |
003 |
ANDA |
FUROSEMIDE |
FUROSEMIDE |
TABLET;ORAL |
80MG |
Prescription |
No |
No |
AB |
2022/10/17
|
GRAVITI PHARMS |